ACELRX PHARMACEUTICALS INC
New Filing
CIK: 0001427925·Pharmaceuticals·DELAWARE·Filed: Jan 24, 2022
Total Offering
$5,960,979
Amount Sold
$5,160,997
Investors
32
First Sale
Jan 7, 2022
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- Yes
Related Persons
| Name | Role |
|---|---|
| Vincent Angotti | Related Person |
| Richard Afable | Related Person |
| Marina Bozilenko | Related Person |
| Mark Edwards | Related Person |
| Stephen Hoffman | Related Person |
| Raffi Asadorian | Related Person |
| Pamela Palmer | Related Person |
| Badri Dasu | Related Person |
| Adrian Adams | Related Person |
| Howard Rosen | Related Person |
| Mark Wan | Related Person |
| Jill Broadfoot | Related Person |
Company
SEC Filing
0001437749-22-001502
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free